Q: These two healthcare stocks have had their troubles lately and are down considerably. You have recommended them in the past, and I'm wondering if you still recommend them as long term dividend stocks? Do you think this is a good entry point or would you wait? Do they have potential to eventually gain momentum and do better?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: What can you tell me about this company and is it a buy, sell, or hold. Thanks for your good work and I will wait for your answer.
-
Gilead Sciences Inc. (GILD $114.77)
-
AbbVie Inc. (ABBV $210.60)
-
Abbott Laboratories (ABT $132.59)
-
Johnson & Johnson (JNJ $179.29)
-
Eli Lilly and Company (LLY $711.68)
-
Merck & Company Inc. (MRK $87.37)
-
Pfizer Inc. (PFE $25.88)
-
WELL Health Technologies Corp. (WELL $4.92)
Q: Hi folks,
I am looking to replace GILD in my TFSA. I currently hold ABBV, LLY, PFE and WELL in other accounts. I am looking for a name that pays a good dividend and has some potential for growth. Can you suggest a couple of names I can take a look at or should I add one of the names I already hold.
Thanks
I am looking to replace GILD in my TFSA. I currently hold ABBV, LLY, PFE and WELL in other accounts. I am looking for a name that pays a good dividend and has some potential for growth. Can you suggest a couple of names I can take a look at or should I add one of the names I already hold.
Thanks
Q: Hi 5i, First thanks for all the feedback on WELL, but I was hoping for a little more information on the performance, valuation and growth aspect for WELL. Earlier I asked if the one analysts view on valuation and direction of company from a pure tech play to a mix of primary care made any sense. I've always been of the opinion that they were a more tech play. Also if you have any pier/competitor comparisons that woul be great. Thanks again for all your assistance.
Q: Hello 5i,
Would you be buyers of Dexcom today? With the recent drop in share price do you think their growth story is attractive? Or is there too much competition in this health/tech space?
Appreciate all you do!
Would you be buyers of Dexcom today? With the recent drop in share price do you think their growth story is attractive? Or is there too much competition in this health/tech space?
Appreciate all you do!
Q: Hi Guys,
Do you think DOC post-pandemic is dead weight in my portfolio and one should just unload it OR is there any hope on the horizon. It’s been bumping along at .12 to .16 forever. Is there anything out there that would give a glimmer of hope?!
Thanks a lot!
Do you think DOC post-pandemic is dead weight in my portfolio and one should just unload it OR is there any hope on the horizon. It’s been bumping along at .12 to .16 forever. Is there anything out there that would give a glimmer of hope?!
Thanks a lot!
Q: Organized meme stock shorting ala GameStop on Well Health? Do you still believe it is not coordinated manipulation? Are there no protections on the TSX to prevent attacks such as this? If a stock is shorted naked, does that prevent it from showing up on the short reports? Do you have insight on how these groups are able to pull this off or at least why this stock is their go-to? Thanks!
Q: Hi team ,
Why is Well crashing today??
Thanks
Shane
Why is Well crashing today??
Thanks
Shane
Q: Do you see anything on your freindly Bloomberg that tells you the reason VRTX is falling in the past week.
Thanks
Sheldon
Thanks
Sheldon
Q: I am considering selling PFE for tax loss. In your opinion is this a good time to sell? Secondly - if I did sell - what might be a good proxy to buy in the meantime and/or - would it be beneficial to rebuy PFE after 30 days. I already have a 4% position in ABBV.
Q: Realizing that PFE's dividend has been rising annually at only about 3% in recent years, and recognizing that a portion of "moving the growth needle" will be done by acquisition, would it still be a good buy at around the $27 level (longterm technical support) ?
Also:
-How does their debt situation compare to its historical measure?
- Do you have any thoughts regarding AI in the sector, and whether or not PFE is currently using it ?
Also:
-How does their debt situation compare to its historical measure?
- Do you have any thoughts regarding AI in the sector, and whether or not PFE is currently using it ?
Q: NVO margins are fantastic and they can’t produce enough ozemic.
I am thinking of starting a position.
If I were to buy one, which one would you prefer ?
I am thinking of starting a position.
If I were to buy one, which one would you prefer ?
Q: Based on your previous comments on Pliant Therapeutics could you please give an opinion on recent earnings and going forward what do you see for the stock and the market they are in. Can you also comment on management and insider ownership if they are worthy enough points to even discuss.
Thank you.
Thank you.
Q: Hello 5i Team,
Can I please get your current opinion on Profound Medical? Do you see it as a buy, given the risk level? The recent earnings call sounded very optimistic with a deal signed to install their prostate cancer/BPH thermal ultrasound treatment in 20 Cleveland Clinics across North America. They also mentioned a code approval in the US effective January 2025. Thanks. Brad
Can I please get your current opinion on Profound Medical? Do you see it as a buy, given the risk level? The recent earnings call sounded very optimistic with a deal signed to install their prostate cancer/BPH thermal ultrasound treatment in 20 Cleveland Clinics across North America. They also mentioned a code approval in the US effective January 2025. Thanks. Brad
Q: Your comments on 3rd quarter results please.
-
Algonquin Power & Utilities Corp. (AQN $8.04)
-
Knight Therapeutics Inc. (GUD $6.45)
-
Canopy Growth Corporation (WEED $1.77)
Q: Hello Peter
Your comments on Knight's , Canopy Growth, and Algonquin Power's results please? Much appreciated
Your comments on Knight's , Canopy Growth, and Algonquin Power's results please? Much appreciated
Q: Would appreciate your assessment of their just released earnings. Clearly the market seems pleased.
Thanks as always.
Thanks as always.
Q: GILD delivers an earnings beat and then the stock falls by $5 over the next couple of days. What is going on? Do you still like it for the long term?
Q: Please comment on latest results
Q: The market is not liking VEEV today. How are their fundamentals? Thanks